COVID-19 and the Heart

Infection with the severe acute respiratory syndrome novel coronavirus produces a clinical syndrome known as 2019 novel coronavirus disease (COVID-19). When severe, COVID-19 is a systemic illness characterized by hyperinflammation, cytokine storm, and elevations of cardiac injury biomarkers. Here, we review what is known about the pathophysiology of COVID-19, its cardiovascular manifestations, and emerging therapeutic prospects. In this rapidly moving field, this review was comprehensive as of April 3, 2020.

• Publication year

  2020

• Venue

  Circulation Research

• Publication date

  2020-04-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCRESAHA.120.317055PMID 32252591PMCID 7188058
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac Surgery During the Coronavirus Disease 2019 Pandemic: Perioperative Considerations and Triage Recommendations

  2020cited by this paper
• Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients?

  2020cited by this paper
• Impact of COVID-19 epidemic on coronary care unit accesses for acute coronary syndrome in Veneto region, Italy

  2020cited by this paper
• Large saddle pulmonary embolism in a woman infected by COVID-19 pneumonia

  2020cited by this paper
• Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis

  2020cited by this paper
• COVID-19 and ECMO: the interplay between coagulation and inflammation—a narrative review

  2020cited by this paper
• Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention in the COVID-19 Era: Comparable Case Volumes but Delayed Symptom Onset to Hospital Presentation

  2020cited by this paper
• QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review

  2020cited by this paper
• Clinical course of 2019 novel coronavirus disease (COVID-19) in individuals present during the outbreak on the Diamond Princess cruise ship

  2020cited by this paper
• Response of Cardiac Surgery Units to COVID-19

  2020cited by this paper
• The role of biomarkers in diagnosis of COVID-19 – A systematic review

  2020cited by this paper
• Reductions in Heart Failure Hospitalizations During the COVID-19 Pandemic

  2020cited by this paper
• Cardiovascular comorbidities, cardiac injury, and prognosis of COVID-19 in New York City

  2020cited by this paper
• The Use of Point-of-Care Lung Ultrasound and Echocardiography in the Management of Coronavirus Disease 2019 (COVID-19)

  2020cited by this paper
• Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19

  2020cited by this paper
• Electron microscopy of SARS-CoV-2: a challenging task – Authors' reply

  2020cited by this paper
• Cardiac Arrhythmias in COVID-19 Infection

  2020cited by this paper
• RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

  2020cited by this paper
• Clinical features of severe patients infected with 2019 novel coronavirus: a systematic review and meta-analysis

  2020cited by this paper
• Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic

  2020cited by this paper
• Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring

  2020cited by this paper
• Chloroquine or Hydroxychloroquine for COVID‐19: Is Cardiotoxicity a Concern?

  2020cited by this paper
• Epicardial adipose tissue: fuel for COVID-19-induced cardiac injury?

  2020cited by this paper
• Myocardial injury in severe COVID-19 infection

  2020cited by this paper
• Impact of COVID‐19 pandemic on ST‐elevation myocardial infarction in a non‐COVID‐19 epicenter

  2020cited by this paper
• Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

  2020cited by this paper
• Echocardiographic Findings in Patients with COVID-19 with Significant Myocardial Injury

  2020cited by this paper
• COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?

  2020cited by this paper
• Approach to Acute Cardiovascular Complications in COVID-19 Infection.

  2020cited by this paper
• When a delayed cardiology consultation leads to a massive left ventricle pseudoaneurysm: collateral effects of the COVID-19 pandemic

  2020cited by this paper
• Faculty Opinions recommendation of Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.

  2020cited by this paper
• Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection

  2020cited by this paper
• Coronary and Structural Heart Disease Interventions During COVID-19 Pandemic: A Road Map for Clinicians and Health Care Delivery Systems

  2020cited by this paper
• A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers

  2020cited by this paper
• Successful Heart Transplantation to a Fulminant Myocarditis Patient during COVID-19 Outbreak – Lessons Learned

  2020cited by this paper
• CMR and serology to diagnose COVID-19 infection with primary cardiac involvement

  2020cited by this paper
• Pathological Findings of Postmortem Biopsies From Lung, Heart, and Liver of 7 Deceased COVID-19 Patients

  2020cited by this paper
• Global evaluation of echocardiography in patients with COVID-19

  2020cited by this paper
• Age and Multimorbidity Predict Death Among COVID-19 Patients

  2020cited by this paper
• Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19

  2020cited by this paper
• New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people

  2020cited by this paper
• COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors

  2020cited by this paper
• The Pan London Emergency Cardiac Surgery service blueprint

  2020cited by this paper
• Retrospective Study of Risk Factors for Myocardial Damage in Patients With Critical Coronavirus Disease 2019 in Wuhan

  2020cited by this paper
• Large intracardiac thrombus in a COVID-19 patient treated with prolonged extracorporeal membrane oxygenation implantation

  2020cited by this paper
• Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells

  2020cited by this paper
• Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.

  2020cited by this paper
• Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

  2020cited by this paper
• A novel coronavirus outbreak of global health concern

  2020cited by this paper
• Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

  2020cited by this paper
• First Case of 2019 Novel Coronavirus in the United States

  2020cited by this paper
• Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

  2020cited by this paper
• A pneumonia outbreak associated with a new coronavirus of probable bat origin

  2020cited by this paper
• Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

  2020cited by this paper
• Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

  2020cited by this paper
• Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

  2020cited by this paper
• Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province

  2020cited by this paper
• Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

  2020cited by this paper
• Presumed Asymptomatic Carrier Transmission of COVID-19.

  2020cited by this paper
• Pathological findings of COVID-19 associated with acute respiratory distress syndrome

  2020cited by this paper
• Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

  2020cited by this paper
• Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

  2020cited by this paper
• Convalescent plasma as a potential therapy for COVID-19

  2020cited by this paper
• Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

  2020cited by this paper
• Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

  2020cited by this paper
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

  2020cited by this paper
• In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

  2020cited by this paper
• How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s Hospital

  2020cited by this paper
• Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

  2020cited by this paper
• Dysregulation of immune response in patients with COVID-19 in Wuhan, China

  2020cited by this paper
• Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

  2020cited by this paper
• The convalescent sera option for containing COVID-19.

  2020cited by this paper
• COVID-19: consider cytokine storm syndromes and immunosuppression

  2020cited by this paper
• [A pathological report of three COVID-19 cases by minimally invasive autopsies].

  2020cited by this paper
• Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin

  2020cited by this paper
• Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia

  2020cited by this paper
• Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China

  2020cited by this paper
• A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

  2020cited by this paper
• Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic

  2020cited by this paper
• Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

  2020cited by this paper
• The coronavirus pandemic in five powerful charts

  2020cited by this paper
• Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.

  2020cited by this paper
• Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).

  2020cited by this paper
• Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.

  2020cited by this paper
• Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

  2020cited by this paper
• Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

  2020cited by this paper
• The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2

  2020cited by this paper
• Covid-19 in Critically Ill Patients in the Seattle Region — Case Series

  2020cited by this paper
• COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal

  2020cited by this paper
• Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

  2020cited by this paper
• High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019

  2020cited by this paper
• Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System

  2020cited by this paper
• Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study

  2020cited by this paper
• Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial

  2020cited by this paper
• Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial

  2020cited by this paper
• Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019

  2020cited by this paper
• ST-Segment Elevation in Patients with Covid-19 — A Case Series

  2020cited by this paper
• COVID-19 Myocarditis and Severity Factors： An Adult Cohort Study

  2020cited by this paper
• Rethinking the role of hydroxychloroquine in the treatment of COVID‐19

  2020cited by this paper
• Effective treatment of severe COVID-19 patients with tocilizumab

  2020cited by this paper

• [Morphological and immunohistochemical characteristics of the heart of patients with COVID-19].

  2026cites this paper
• COVID-19 and Myocarditis: Trends, Clinical Characteristics, and Future Directions

  2025cites this paper
• Deep insight into cytokine storm: from pathogenesis to treatment

  2025cites this paper
• Integrated Multiomics Reveals Alterations in Paucimannose and Complex Type N-Glycans in Cardiac Tissue of Patients with COVID-19

  2025cites this paper
• Heterozygous interferon signaling deficient mice as animal models for Chikungunya virus infection in the heart

  2025cites this paper
• Subtle changes on electrocardiogram in severe patients with COVID-19 may be predictors of treatment outcome

  2025cites this paper
• Meta-Data Analysis to Explore the Interaction of the Hub-Genes interlinking SARS-CoV-2 and Cardiovascular Diseases

  2025cites this paper
• Meta-analysis of mortality factors after COVID-19 infection in pediatric oncology patients

  2025cites this paper
• Diagnosis of Cardiac Amyloidosis in South Asia: Need for a Collaborative Approach from Researchers and Clinicians.

  2025cites this paper
• Silent Invasion: COVID-19′s Hidden Damage to Human Organs

  2025cites this paper
• Cardiac structure and function 1.5 years after COVID-19: results from the EPILOC study

  2025cites this paper
• Exploring best-performing radiomic features with combined multilevel discrete wavelet decompositions for multiclass COVID-19 classification using chest X-ray images

  2025cites this paper
• Prognosis of patients with acute myocardial infarction in the setting of COVID-19: A French nationwide observational study.

  2025cites this paper
• Fulminant myocarditis induced by SARS-CoV-2 infection without severe lung involvement: insights into COVID-19 pathogenesis.

  2024cites this paper
• Impact of High Troponin Level on the Outcome in COVID-19 Positive Patients

  2024cites this paper
• Endosomal Toll-Like Receptors intermediate negative impacts of viral diseases, autoimmune diseases, and inflammatory immune responses on the cardiovascular system

  2024cites this paper
• Symptom burden, coagulopathy and heart disease after acute SARS-CoV-2 infection in primary practice

  2024cites this paper
• The application status of sequencing technology in global respiratory infectious disease diagnosis

  2024cites this paper
• Cardiovascular Magnetic Resonance Reveals Cardiac Inflammation and Fibrosis in Symptomatic Patients with Post-COVID-19 Syndrome: Findings from the INSPIRE-CMR Multicenter Study

  2024cites this paper
• Lessons Learned From Extracorporeal Life Support Practice and Outcomes During the COVID‐19 Pandemic

  2024cites this paper
• Improved kidney function is associated with Colchicine treatment in COVID-19 patients

  2024cites this paper
• Unraveling the relevance of SARS-Cov-2 infection and ferroptosis within the heart of COVID-19 patients

  2024cites this paper
• Coronavirus disease 2019–related myocardial injury is associated with immune dysregulation in symptomatic patients with cardiac magnetic resonance imaging abnormalities

  2024cites this paper
• COVID-19 related acute necrotizing encephalopathy and acute myocarditis in an adult female: a novel case report of brain injury and myocarditis

  2024cites this paper
• Cardiac Function and Structure before and after Mild SARS-CoV-2 Infection in Elite Athletes Using Biventricular and Left Atrial Strain

  2024cites this paper
• Medical examination of divers after COVID-19 infection: a prospective, observational study using published (original and revised) guidelines for evaluation.

  2024cites this paper
• Cardiovascular disease risk after a SARS-CoV-2 infection: a systematic review and meta-analysis.

  2024cites this paper
• Coronary Implications of COVID-19

  2024cites this paper
• The investigation of the frequency of COVID-19 in patients with a history of stroke

  2024cites this paper
• Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19

  2024cites this paper
• P-selectin Facilitates SARS-CoV-2 Spike 1 Subunit Attachment to Vesicular Endothelium and Platelets.

  2024cites this paper
• Coordination chemistry suggests that independently observed benefits of metformin and Zn2+ against COVID-19 are not independent

  2024cites this paper
• Clinical and Laboratory Profile, Management and Outcome of Pediatric SARS-CoV-2 Infection Admitted at the Philippine General Hospital

  2024cites this paper
• COVID-19 electrochemical immunosensor with Ag-MOF: Rapid and high-selectivity nasal swab testing for effective detection.

  2024cites this paper
• Microfluidic Immunoarray for Point-of-Care Detection of Cytokines in COVID-19 Patients

  2024cites this paper
• [Features of treatment and rehabilitation of COVID-19 patients with ischemic stroke].

  2023cites this paper
• Pneumonia-Induced Inflammation, Resolution and Cardiovascular Disease: Causes, Consequences and Clinical Opportunities

  2023cites this paper
• Revisiting the COVID-19 Pandemic: An Insight into Long-Term Post-COVID Complications and Repurposing of Drugs

  2023cites this paper
• Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection

  2023cites this paper
• Thymus vulgaris, a natural pharmacy against COVID-19: A molecular review

  2023cites this paper
• Pediatric Pericarditis: Update

  2023cites this paper
• Echocardiographic manifestations during the first 3 months after an episode of COVID-19 and their relationship with disease severity and persistence of symptoms

  2023cites this paper
• Clinical profile and the extent of residual myocardial dysfunction among patients with previous coronavirus disease 2019

  2023cites this paper
• Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients

  2023cites this paper
• Left atrial strain is associated with distinct inflammatory and immune profile in patients with COVID-19 pneumonia

  2023cites this paper
• SARS-CoV-2 and its impact on the cardiovascular and digestive systems – The interplay between new virus variants and human cells

  2023cites this paper
• Use of strain imaging to detect subtle myocardial involvement in post COVID-19 patients: An Indian perspective

  2023cites this paper
• Relation of exercise intolerance to microvascular dysfunction in COVID-19 recovered patients after six months of recovery

  2023cites this paper
• Subclinical Left Ventricular Systolic Dysfunction in Hospitalized Patients with COVID-19 by Strain: A 30-Day Echocardiographic Follow-Up

  2023cites this paper
• IL-6 and SAA—Strong Predictors for the Outcome in COVID-19 CKD Patients

  2023cites this paper
• Sequence and directivity in cardiac muscle injury of COVID-19 patients: an observational study

  2023cites this paper
• Heparan Sulfate-Mimicking Glycopolymers Bind SARS-CoV-2 Spike Protein in a Length- and Sulfation Pattern-Dependent Manner.

  2023cites this paper
• Validity and reliability of the Arabic Fear of COVID-19 Scale in Lebanese people during the pandemic

  2023cites this paper
• A Population-Based Outcome-Wide Association Study of the Comorbidities and Sequelae Following COVID-19 Infection

  2023cites this paper
• Evaluation of cardiovascular autonomic dysfunction in symptomatic post-COVID-19 patients using the heart rate variability (HRV) and detection of subtle LV dysfunction using 2D global longitudinal strain (GLS)

  2023cites this paper
• A role for Toll-like receptor 3 in lung vascular remodeling associated with SARS-CoV-2 infection

  2023cites this paper
• Vitronectin promotes immunothrombotic dysregulation in the venular microvasculature

  2023cites this paper
• The paradigm of prophylactic viral outbreaks measures by microbial biosurfactants

  2023cites this paper
• Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2

  2023cites this paper
• Long-Term Adverse Effects of Mild COVID-19 Disease on Arterial Stiffness, and Systemic and Central Hemodynamics: A Pre-Post Study

  2023cites this paper
• COVID-19-Induced Myocarditis: Pathophysiological Roles of ACE2 and Toll-like Receptors

  2023cites this paper
• Left Ventricular Global Longitudinal Strain as a Parameter of Mild Myocardial Dysfunction in Athletes after COVID-19

  2023cites this paper
• Post-COVID Cardiomyopathy

  2023cites this paper
• Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone

  2023cites this paper
• The role of myocardial perfusion imaging in predicting myocardial ischemia in patients diagnosed with long COVID

  2023cites this paper
• Cardiovascular complications in coronavirus disease-2019 patients

  2023cites this paper
• Discovery of dual S-RBD/NRP1-targeting peptides: structure-based virtual screening, synthesis, biological evaluation, and molecular dynamics simulation studies

  2023cites this paper
• Bayesian machine learning analysis with Markov Chain Monte Carlo techniques for assessing characteristics and risk factors of Covid-19 in Erbil City-Iraq 2020–2021

  2023cites this paper
• Novel cardiovascular and pulmonary findings in the non-invasive ischemic assessment of patients with Coronavirus 2019 (COVID-19).

  2023cites this paper
• TCM “medicine and food homology” in the management of post-COVID disorders

  2023cites this paper
• Outcomes of viral myocarditis in patients with and without COVID-19: a nationwide analysis from the United States

  2023cites this paper
• Myopericarditis as a Delayed Complication of COVID-19 Infection: A Case Report

  2023cites this paper
• Assessment of myocardial function and cardiac performance using left ventricular global longitudinal strain in athletes after COVID-19: a follow-up study

  2023cites this paper
• Cardiac Muscle Injury and Echocardiographic Plus Electrocardiographic Findings in Patients With 2019 Novel Coronavirus (COVID-19): A Retrospective Cohort Study

  2023cites this paper
• Interaction of COVID-19 With Common Cardiovascular Disorders

  2023cites this paper
• Persisting Shadows: Unraveling the Impact of Long COVID-19 on Respiratory, Cardiovascular, and Nervous Systems

  2023cites this paper
• Subclinical Myocardial Injury in Patients Recovered from COVID-19 Pneumonia: Predictors and Longitudinal Assessment

  2023cites this paper
• The role of epicardial adipose tissue dysfunction in cardiovascular diseases: an overview of pathophysiology, evaluation, and management

  2023cites this paper
• COVID-19 Infection and Vaccination and Its Relation to Amyloidosis: What Do We Know Currently?

  2023cites this paper
• Early referring saved lives in kidney transplant recipients with COVID-19: a beneficial role of telemedicine

  2023cites this paper
• The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical)

  2023cites this paper
• The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes

  2022cites this paper
• Primary adrenal insufficiency and myocarditis in COVID-19 disease: a case report

  2022cites this paper
• Development and Validation of a Mobile Application as an Adjuvant Treatment for People Diagnosed with Long COVID-19: Protocol for a Co-Creation Study of a Health Asset and an Analysis of Its Effectiveness and Cost-Effectiveness

  2022cites this paper
• Prospective multicenter study of heart rate variability with ANI monitor as predictor of mortality in critically ill patients with COVID-19

  2022cites this paper
• [Clinical and pathophysiological features of stroke in patients with COVID-19].

  2022cites this paper
• A Bitter Experience That Enlightens the Future: COVID-19 Neurological Affection and Perspectives on the Orexigenic System

  2022cites this paper
• Immune response induced by novel coronavirus infection

  2022cites this paper
• Predictive markers for clinical outcomes in a cohort of diabetic patients hospitalized for COVID-19

  2022cites this paper
• Early carbohydrate antigen 125 as a mortality predictor in hospitalized patients with coronavirus disease 2019

  2022cites this paper
• Coronavirus disease 2019 death prediction by electrocardiographic abnormalities and elevated D-dimer levels

  2022cites this paper
• Theranostic efficiency of biosurfactants against COVID-19 and similar viruses - A review

  2022cites this paper
• Role of biological markers and CT severity score in predicting mortality in patients with COVID‑19: An observational retrospective study.

  2022cites this paper
• Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection

  2022cites this paper
• Association of COVID-19 with endocarditis in patients with cocaine or opioid use disorders in the US

  2022cites this paper
• (Epi)transcriptomics in cardiovascular and neurological complications of COVID-19

  2022cites this paper
• Eccentric Training in Pulmonary Rehabilitation of Post-COVID-19 Patients: An Alternative for Improving the Functional Capacity, Inflammation, and Oxidative Stress

  2022cites this paper
• SARS-CoV-2 and HIV-1: So Different yet so Alike. Immune Response at the Cellular and Molecular Level

  2022cites this paper
• Cardiac involvement in patients 1 year after recovery from moderate and severe COVID-19 infections

  2022cites this paper
• Cardiac Involvement in COVID-19: A Global Bibliometric and Visualized Analysis

  2022cites this paper